Navigation Links
DuPont Joint Venture with Chinese Biotech Firm Strengthens Gene Discovery Research Efforts
Date:12/3/2007

Partnership Will Focus on Identifying New Biotech Traits to Improve Farmer

Productivity

BEIJING, Dec. 3 /PRNewswire-FirstCall/ -- DuPont and Beijing Weiming Kaituo Agriculture Biotechnology Co., Ltd. (BWK) today announced the formation of a joint venture to accelerate the discovery of genes for high value agronomic traits such as stress tolerance and efficient nutrient utilization to improve the performance of important crops for farmers in China and throughout the world. For DuPont, this marks another step toward the globalization of its R&D capabilities to accelerate new product launches and drive business growth for its worldwide seed business, Pioneer Hi-Bred. The financial terms of the agreement were not disclosed.

"Novel trait combinations that provide plants with genetic solutions to successfully confront the challenges of water and nutrient deficiencies and cope with unfavorable wind and temperature extremes resonate with every farmer I've ever worked with," said Bill Niebur, DuPont vice president, Crop Genetics Research and Development. "This new joint venture brings together industry- leading biotechnology researchers to develop enabling technologies and discover new genes for important agronomic traits that can further improve farmer productivity and profitability globally. BWK's strengths in functional genomics and molecular breeding will make a major impact across our entire product pipeline."

Peking University and its affiliate, Peking University Weiming Biotech Group Co., Ltd., are significant participants in the joint venture through an ownership stake in BWK.

"We are excited to work with DuPont to advance research of important agronomic traits for improving agricultural crop production," said Dr. Zhihong Xu, president of Peking University. "Through this joint venture, we will be able to expand our world-class research efforts to benefit farmers in China and around the world."

T
'/>"/>

SOURCE DuPont
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. DuPont Leaders Brief Investors on Agriculture Businesses
2. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
3. DuPont and Plantic Technologies Announce Starch-Based Bio Materials Collaboration
4. DuPont Named Among Top Biotechnology Employers by Science Magazine
5. Biotechnology Needed to Help Meet Growing Global Needs for Food, Feed, Fuel and Materials, DuPont Chairman & CEO Says at World Food Prize
6. Biopure Gives Update on Malaysia Joint Venture Discussions
7. FDA and Conformia Deliver Joint Presentation to Annual Regulatory and Compliance Symposium at Harvard
8. BSP Pharma Inc., Makers of FlexNow(TM) Joint Formula Sign Distribution Deal with Vitamin Shoppe and GNC
9. Siemens and Xintek Form Joint Venture to Develop Nanotechnology-Enabled Multi-Pixel X-ray Tubes
10. Elbit Medical Imaging Ltd. Announces that Plaza Centers Has Entered into a Joint Venture Partnership to Develop Residential and Office Projects in Romania
11. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ov.25/PRNewswire/--BiotechfirmReplikinsLtd.,whichh...micthroughtheprediction,outbreak,andprogressofthec...analysisofthevirus.Thenewdatashowsthatthelethality....7(s.d.4.5)duringthevirus,scurrentoutbreakinthespr...s.d.0.1).TheH1N1virus,infectivitycount,however,rem...
(Date:11/25/2009)...Nov.25/PRNewswire/--Reportlinker.comannouncesthata...,, BrazilBioethanolMarketAnalysisandForecastst.../Brazil-Bioethanol-Market-Analysis-and-Forecasts-t...ndForecaststo2013 ,, Summary ,, Thereportp...thanolmarketandtheBrazilbioethanolmarketinparticul...
(Date:11/24/2009)... The New York investment bank KTA Capital... agreed an AU$6.7 mil convertible note private pla...vate placement was arranged by KTA Capital as Neur... New York (PRWEB) November 23,...KTA Capital, LLC ("KTA Capital") has ann...
(Date:11/24/2009)... Health care employment grew by 29,000 ...e to show consistent growth during the U.S. recess...in in trouble, and health systems are coming close...tead of just administrators. , ...loyment continued growing in October despite the s...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4
...Chain Visibility , , BEVERLY, Mass., Jan. 7 Se...bility solutions, has launched the TempTale(R)4USB...ta management. This latest model of the industry-l...data access at shipment receiving sites without pr...ly owned subsidiary of Carrier Corp., a business u...
...Jan. 7 Poniard,Pharmaceuticals, Inc. (Nasdaq: P...vative oncology therapies, today announced that th... 2 clinical trials of picoplatin at two upcoming,A...ia. , In January, the Company will present upd...patients with metastatic colorectal cancer at ASCO...
...tradigm Corporation, a leading,developer of target... today,announced that the company has closed the f...enture Management led the $2.9 million tranche, wi...pating. The addition of these,funds brings the to...m will,use Series B funds to advance its RNAi ther...
Other Biology Technology:Introducing Sensitech's TempTale(R)4USB Temperature Monitor 2Introducing Sensitech's TempTale(R)4USB Temperature Monitor 3Poniard Pharmaceuticals to Present Data from Phase 2 Clinical Trials of Picoplatin in Colorectal and Prostate Cancers 2Poniard Pharmaceuticals to Present Data from Phase 2 Clinical Trials of Picoplatin in Colorectal and Prostate Cancers 3Intradigm Closes Final Tranche of $21.4 Million Series B Financing 2Intradigm Closes Final Tranche of $21.4 Million Series B Financing 3
(Date:11/25/2009)...h, Head of the Cell Death Research Laboratory in t...s been awarded the prestigious Johnson & Johnson F...e cause of brain cell damage in Parkinson,s diseas...ists in support of innovation and excellence in sc...rred earlier this month at an event at the Hyatt R...
(Date:11/25/2009)... you eat may be just as vital to your health as wh...e for Biological Studies. Their experiments in mic...usands of genes in the liverthe body,s metabolic c...d not by the body,s circadian clock as conventiona...the activity of a large number of genes completely...
(Date:11/24/2009)...ystallised a protein that may help gut bacteria bi...d be used by probiotic producers to identify strai.... , "Probiotics need to interact with cells linin... attach to surfaces in the gut they are more likel...ity," says Dr Nathalie Juge from the Institute of ...
Breaking Biology News(10 mins):Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Feeding the clock 2Feeding the clock 3A sticky solution for identifying effective probiotics 2Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress 3B Emotional Issues can be a Significant Contributing Factor 60921 1Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress 3B Emotional Issues can be a Significant Contributing Factor 60921 2Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress 3B Emotional Issues can be a Significant Contributing Factor 60921 3Therapure Biopharma Inc Announces Delivery of its First Commercial Scale Lyophilizer 60919 1Therapure Biopharma Inc Announces Delivery of its First Commercial Scale Lyophilizer 60919 2Pennsylvania Jury Awards 242 3 Million to Fayette County Woman in Medical Malpractice Case 60917 1Pennsylvania Jury Awards 242 3 Million to Fayette County Woman in Medical Malpractice Case 60917 2
...ientists from the National Institute of Allergy an...l Institutes of Health, have determined how a prom...uses tuberculosis (TB). Published online this week...s, the finding may help scientists optimize the dr...tuberculosis (M. tb). , "PA-824, now in early sta...
...though researchers over recent years have establis...gainst cancer, the mechanisms by which it might co...d. In work reported this week, researchers studyin...at despite the protective role of p53 as a guardia...tivity--at least in some cell types--may indeed co...
...udy appears in ScienceJust as hurricanes in the Gu...holera outbreaks, researchers at Harvard Medical S...inst the cholera bacteria. While traditional antib...processes essential for their survival, the new ag...ause the severe diarrhea associated with Vibrio ch...
Other Biology News:NIAID researchers show how promising TB drug works 2NIAID researchers show how promising TB drug works 3New clues to the dark side of a key anti-tumor guardian 2
Amido Black 10B, CI 20470 from Research Organics, Inc.
FCS File Sanitizer from Verity Software House
Anti-FAK, phospho (Tyr576 / Tyr577) Antibody, Unconjugated from Cell Signaling Technology
Anti-Latanoprost (EIA Antiserum) Antibody, Unconjugated from Cayman Chemical
Biology Products: